Pharmacological analysis of cyclooxygenase-1 in inflammation
about
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expressionOral non-steroidal anti-inflammatory drugs (single dose) for perineal pain in the early postpartum periodReciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implicationsRole of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic painFibro-vascular coupling in the control of cochlear blood flowOxicams Bind in a Novel Mode to the Cyclooxygenase Active Site via a Two-water-mediated H-bonding NetworkDifferential metabolism of dihomo-gamma-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: implications for cellular synthesis of prostaglandin E1 and prostaglandin E2Delay in oral mucosal ulcer healing by aspirin is linked to the disturbances in p38 mitogen-activated protein kinase activationInhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivoCOX-2 and cancer: a new approach to an old problemDose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibitionKaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cellsCox-2 inhibitor attenuates NO-induced nNOS in rat caudal trigeminal nucleusSelective cyclo-oxygenase-2 inhibition with celecoxib elevates blood pressure and promotes leukocyte adherenceA three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitorsThe prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressureDisturbance of peristalsis in the guinea-pig isolated small intestine by indomethacin, but not cyclo-oxygenase isoform-selective inhibitorsEffects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challengeThromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardiaOpposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin IICyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteriesGastroprotective mechanism of Paederia foetida Linn. (Rubiaceae)--a popular edible plant used by the tribal community of North-East India.Early vasodilator response to anodal current application in human is not impaired by cyclooxygenase-2 blockade.Role of hydroquinone-thiol conjugates in benzene-mediated toxicityCyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer's and Other Neurodegenerative Diseases.Cyclooxygenase-deficient mice. A summary of their characteristics and susceptibilities to inflammation and carcinogenesis.Beneficial effect of ultra-low-dose aspirin in platelet activity alterations and haemorrhage observed in experimental portal hypertension.COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration.Potential utility of COX-2 inhibitors in chemoprevention and chemotherapy.Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.The development of COX2 inhibitors.Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis.The Effect of Cadmium on COX-1 and COX-2 Gene, Protein Expression, and Enzymatic Activity in THP-1 Macrophages.Cyclooxygenase (COX) 1 and 2 in normal, inflamed, and ulcerated human gastric mucosa.Histone deacetylase 3 antagonizes aspirin-stimulated endothelial nitric oxide production by reversing aspirin-induced lysine acetylation of endothelial nitric oxide synthase.Design of Fluorine-Containing 3,4-Diarylfuran-2(5H)-ones as Selective COX-1 Inhibitors.The activity against leukocyte eicosanoid generation of essential oil and polar fractions of Adesmia boronioides Hook.f.Inhibition of cyclooxygenase-2 prevents adverse effects induced by phosphodiesterase type 4 inhibitors in rats
P2860
Q24536398-127142E1-0F50-48CD-B22C-A5C33026E1BCQ26471110-F8541488-527F-487C-B9E5-0792C7934FA0Q26852195-70E83226-8E1D-46DC-A632-66FE1FC05948Q27329693-B10A58E0-4846-4093-A2E3-9C9D8254B116Q27336005-EE9332EB-A765-49EB-9D6E-B966AD449962Q27681344-0CF0E563-7771-4C5D-9E82-49777EC2B20BQ27863314-F40FA628-CE47-45C9-B89F-FE449DB0E892Q28186400-315D0409-88FA-4E10-8A8A-7DF9380BA2E5Q28188254-BBE9574E-A80A-49FC-88A2-A97F01F093EBQ28191533-93073630-6232-4DF1-BB46-1F8E2A0002B6Q28213226-78E8FC25-2D1F-4F5A-BF1D-80E73A23E496Q28221605-236A6052-7AE1-45A1-A4EC-1829B851D1B7Q28222552-791D1EBA-FFDB-4605-A316-7AA6651FC375Q28344081-FABD35C2-D994-45EC-9AF6-6035A709474EQ28344403-F3641511-0D68-4686-A6DC-395920A99F2CQ28346548-BC1F8CAA-3A48-40FB-90CD-E3C62AC8F2BCQ28360204-F355AFA3-CBE3-4E5A-974D-4EB7FD33F6BFQ28361239-F5E1BA41-735B-458E-92A9-0C2B9FAC0DF7Q28507047-402B9DA2-D950-495B-B0EF-970DCF729480Q28508911-FCC2AE7B-1108-4A38-9EEB-7015E36E810EQ28582888-3D45F614-9429-42D7-83EE-EB8C070B0887Q30387731-E525B419-63BF-4A87-967E-DF846D6CDB65Q31131984-740BF03E-73CC-4DCB-8BE8-9B27C9B0961AQ33756005-AC43D895-1D00-498C-AE31-7D9844F2FB21Q33801163-93901949-ADAC-4456-9C31-9DF5F0D69323Q33822140-9934C9BA-8A2A-4AEE-BAF6-4819604918B5Q33832795-673B0D90-43F7-4A5C-B86F-3DA9C34E17D3Q33834295-2CA76D5F-7EC6-4620-BED0-763E02F118BDQ34111114-A9AFE6A6-7143-40FB-A269-592ED5D15654Q34119479-F67C1D2F-865A-40D1-9B56-C3A5E14A0E06Q34119511-1D12A582-03C5-42D7-97D0-69314D775591Q34134282-75085C0F-307F-4DF0-806A-936230D241E7Q34180681-6AEA2782-9FDB-4C91-9E40-ABDD2E3FC950Q34240778-0C9B6877-915B-40CB-BA5D-E879BB081743Q34461005-A66F9974-41A7-44C9-82AA-4B7E5B6099A6Q34511855-7A52A539-6F43-411E-996E-8E54740266A2Q34514079-BDEC355B-1B69-45DB-9ACA-F1EEFCC4949BQ34519695-002353AA-2837-4766-8D11-B26B271C4C76Q34532482-CF0F6EB9-AEB8-49AE-B309-C92092513DFDQ34540209-BCE3F5C6-65CE-44B0-A879-E13E149554F1
P2860
Pharmacological analysis of cyclooxygenase-1 in inflammation
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Pharmacological analysis of cyclooxygenase-1 in inflammation
@ast
Pharmacological analysis of cyclooxygenase-1 in inflammation
@en
type
label
Pharmacological analysis of cyclooxygenase-1 in inflammation
@ast
Pharmacological analysis of cyclooxygenase-1 in inflammation
@en
prefLabel
Pharmacological analysis of cyclooxygenase-1 in inflammation
@ast
Pharmacological analysis of cyclooxygenase-1 in inflammation
@en
P2093
P2860
P356
P1476
Pharmacological analysis of cyclooxygenase-1 in inflammation
@en
P2093
Isakson PC
Koboldt CM
Masferrer JL
Muhammad J
Zweifel BS
P2860
P304
13313-13318
P356
10.1073/PNAS.95.22.13313
P407
P577
1998-10-01T00:00:00Z